These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20514016)

  • 1. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2009 Nov; ():. PubMed ID: 19915613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
    Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
    Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].
    Fujita Y; Nishio K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):923-6. PubMed ID: 19542713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient identification of miRNAs for classification of tumor origin.
    Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
    J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
    De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
    Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying tumor origin using a gene expression-based classification map.
    Buckhaults P; Zhang Z; Chen YC; Wang TL; St Croix B; Saha S; Bardelli A; Morin PJ; Polyak K; Hruban RH; Velculescu VE; Shih IeM
    Cancer Res; 2003 Jul; 63(14):4144-9. PubMed ID: 12874019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin.
    Dennis JL; Vass JK; Wit EC; Keith WN; Oien KA
    Cancer Res; 2002 Nov; 62(21):5999-6005. PubMed ID: 12414618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of human carcinomas by use of gene expression signatures.
    Su AI; Welsh JB; Sapinoso LM; Kern SG; Dimitrov P; Lapp H; Schultz PG; Powell SM; Moskaluk CA; Frierson HF; Hampton GM
    Cancer Res; 2001 Oct; 61(20):7388-93. PubMed ID: 11606367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs accurately identify cancer tissue origin.
    Rosenfeld N; Aharonov R; Meiri E; Rosenwald S; Spector Y; Zepeniuk M; Benjamin H; Shabes N; Tabak S; Levy A; Lebanony D; Goren Y; Silberschein E; Targan N; Ben-Ari A; Gilad S; Sion-Vardy N; Tobar A; Feinmesser M; Kharenko O; Nativ O; Nass D; Perelman M; Yosepovich A; Shalmon B; Polak-Charcon S; Fridman E; Avniel A; Bentwich I; Bentwich Z; Cohen D; Chajut A; Barshack I
    Nat Biotechnol; 2008 Apr; 26(4):462-9. PubMed ID: 18362881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus analysis of multiple classifiers using non-repetitive variables: diagnostic application to microarray gene expression data.
    Su Z; Hong H; Perkins R; Shao X; Cai W; Tong W
    Comput Biol Chem; 2007 Feb; 31(1):48-56. PubMed ID: 17303535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
    Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
    Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
    Pentheroudakis G; Golfinopoulos V; Pavlidis N
    Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of unknown primary site: missing primary or missing biology?
    Pentheroudakis G; Briasoulis E; Pavlidis N
    Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.
    Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Singh V; Carey B; Erlander MG; Highsmith WE; Dry SM; Brachtel EF
    Clin Cancer Res; 2012 Jul; 18(14):3952-60. PubMed ID: 22648269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
    Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
    Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.